Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 352

1.

Finerenone Reduces Intrinsic Arterial Stiffness in Munich Wistar Frömter Rats, a Genetic Model of Chronic Kidney Disease.

Gil-Ortega M, Vega-Martín E, Martín-Ramos M, González-Blázquez R, Pulido-Olmo H, Ruiz-Hurtado G, Schulz A, Ruilope LM, Kolkhof P, Somoza B, Kreutz R, Fernández-Alfonso MS.

Am J Nephrol. 2020 Feb 21:1-10. doi: 10.1159/000506275. [Epub ahead of print]

PMID:
32088716
2.

Deficits in pain medication in older adults with chronic pain receiving home care: A cross-sectional study in Germany.

Schneider J, Algharably E, Budnick A, Wenzel A, Dräger D, Kreutz R.

PLoS One. 2020 Feb 21;15(2):e0229229. doi: 10.1371/journal.pone.0229229. eCollection 2020.

3.

Update of the position paper on arterial hypertension and erectile dysfunction.

Viigimaa M, Vlachopoulos C, Doumas M, Wolf J, Imprialos K, Terentes-Printzios D, Ioakeimidis N, Kotsar A, Kiitam U, Stavropoulos K, Narkiewicz K, Manolis A, Jelakovic B, Lovic D, Kreutz R, Tsioufis K, Mancia G; European Society of Hypertension Working Group on Sexual Dysfunction.

J Hypertens. 2020 Feb 18. doi: 10.1097/HJH.0000000000002382. [Epub ahead of print]

PMID:
32073535
4.

Impact of single-pill combination therapy on adherence, blood pressure control, and clinical outcomes: a rapid evidence assessment of recent literature.

Tsioufis K, Kreutz R, Sykara G, van Vugt J, Hassan T.

J Hypertens. 2020 Feb 12. doi: 10.1097/HJH.0000000000002381. [Epub ahead of print]

PMID:
32053523
5.

Pain-Associated Clusters Among Nursing Home Residents and Older Adults Receiving Home Care in Germany.

Budnick A, Kuhnert R, Wenzel A, Tse M, Schneider J, Kreutz R, Dräger D.

J Pain Symptom Manage. 2020 Feb 7. pii: S0885-3924(20)30070-1. doi: 10.1016/j.jpainsymman.2020.01.018. [Epub ahead of print]

PMID:
32044425
6.

Nutraceuticals and blood pressure control: a European Society of Hypertension position document.

Borghi C, Tsioufis K, Agabiti-Rosei E, Burnier M, Cicero AFG, Clement D, Coca A, Desideri G, Grassi G, Lovic D, Lurbe E, Kahan T, Kreutz R, Jelakovic B, Polonia J, Redon J, Van De Borne P, Mancia G.

J Hypertens. 2020 Jan 20. doi: 10.1097/HJH.0000000000002353. [Epub ahead of print]

PMID:
31977574
7.

Potentially inappropriate medication in older participants of the Berlin Aging Study II (BASE-II) - Sex differences and associations with morbidity and medication use.

Toepfer S, Bolbrinker J, König M, Steinhagen-Thiessen E, Kreutz R, Demuth I.

PLoS One. 2019 Dec 30;14(12):e0226511. doi: 10.1371/journal.pone.0226511. eCollection 2019.

8.

Suggestions for improving the design of clinical trials in multiple sclerosis-results of a systematic analysis of completed phase III trials.

Gehr S, Kaiser T, Kreutz R, Ludwig WD, Paul F.

EPMA J. 2019 Nov 22;10(4):425-436. doi: 10.1007/s13167-019-00192-z. eCollection 2019 Dec. Review.

9.

Cardiovascular, renal and liver protection with novel antidiabetic agents beyond blood glucose lowering in type 2 diabetes: consensus article from the European Society of Hypertension Working Group on Obesity, Diabetes and the High-risk Patient.

Kotsis V, Jordan J, Stabouli S, Antza C, Micic D, Jelaković B, Schlaich MP, Nilsson PM, Kreutz R, Mancia G, Tsioufis K, Grassi G.

J Hypertens. 2020 Mar;38(3):377-386. doi: 10.1097/HJH.0000000000002279.

PMID:
31764586
10.

The Impact of Measurement Methods on Office Blood Pressure and Management of Hypertension in General Practice.

Höller J, Villagomez Fuentes LE, Matthias K, Kreutz R.

High Blood Press Cardiovasc Prev. 2019 Dec;26(6):483-491. doi: 10.1007/s40292-019-00347-z. Epub 2019 Nov 9.

PMID:
31705461
11.

Patterns of medication use and the burden of polypharmacy in patients with chronic kidney disease: the German Chronic Kidney Disease study.

Schmidt IM, Hübner S, Nadal J, Titze S, Schmid M, Bärthlein B, Schlieper G, Dienemann T, Schultheiss UT, Meiselbach H, Köttgen A, Flöge J, Busch M, Kreutz R, Kielstein JT, Eckardt KU.

Clin Kidney J. 2019 May 24;12(5):663-672. doi: 10.1093/ckj/sfz046. eCollection 2019 Oct.

12.

[Pain situation among older adults in need of care in the outpatient care setting and cognitively or physically unable to respond : Challenges and recommendations].

Budnick A, Wenzel A, Schneider J, Paschke-Duke M, Kreutz R, Dräger D.

Schmerz. 2019 Dec;33(6):523-532. doi: 10.1007/s00482-019-00404-5. German.

PMID:
31478144
13.

Rivaroxaban's Impact on Renal Decline in Patients With Nonvalvular Atrial Fibrillation: A US MarketScan Claims Database Analysis.

Coleman CI, Kreutz R, Sood N, Bunz TJ, Meinecke AK, Eriksson D, Baker WL.

Clin Appl Thromb Hemost. 2019 Jan-Dec;25:1076029619868535. doi: 10.1177/1076029619868535.

14.

Glomerular C4d deposition can precede the development of focal segmental glomerulosclerosis.

van de Lest NA, Zandbergen M, Wolterbeek R, Kreutz R, Trouw LA, Dorresteijn EM, Bruijn JA, Bajema IM, Scharpfenecker M, Chua JS.

Kidney Int. 2019 Sep;96(3):738-749. doi: 10.1016/j.kint.2019.04.028. Epub 2019 May 16.

PMID:
31327475
15.

Fixed-dose combination antihypertensive medications.

Benjamin IJ, Kreutz R, Olsen MH, Schutte AE, Lopez-Jaramillo P, Frieden TR, Sliwa K, Lackland DT, Brainin M.

Lancet. 2019 Aug 24;394(10199):637-638. doi: 10.1016/S0140-6736(19)31629-0. Epub 2019 Jul 15. No abstract available.

PMID:
31320200
16.

Patient Management Strategies and Long-Term Outcomes in Isolated Distal Deep-Vein Thrombosis versus Proximal Deep-Vein Thrombosis: Findings from XALIA.

Ageno W, Mantovani LG, Haas S, Kreutz R, Monje D, Schneider J, Bugge JP, Gebel M, Turpie AGG.

TH Open. 2019 Mar 26;3(1):e85-e93. doi: 10.1055/s-0039-1683968. eCollection 2019 Jan.

17.

Reviewing the effects of thiazide and thiazide-like diuretics as photosensitizing drugs on the risk of skin cancer.

Kreutz R, Algharably EAH, Douros A.

J Hypertens. 2019 Oct;37(10):1950-1958. doi: 10.1097/HJH.0000000000002136.

PMID:
31145177
18.

Rivaroxaban Versus Warfarin in Patients With Nonvalvular Atrial Fibrillation and Severe Kidney Disease or Undergoing Hemodialysis.

Coleman CI, Kreutz R, Sood NA, Bunz TJ, Eriksson D, Meinecke AK, Baker WL.

Am J Med. 2019 Sep;132(9):1078-1083. doi: 10.1016/j.amjmed.2019.04.013. Epub 2019 May 2.

PMID:
31054829
19.

Exposure to vitamin k antagonists and kidney function decline in patients with atrial fibrillation and chronic kidney disease.

Posch F, Ay C, Stöger H, Kreutz R, Beyer-Westendorf J.

Res Pract Thromb Haemost. 2019 Mar 5;3(2):207-216. doi: 10.1002/rth2.12189. eCollection 2019 Apr.

20.

Analysis of the genomic architecture of a complex trait locus in hypertensive rat models links Tmem63c to kidney damage.

Schulz A, Müller NV, van de Lest NA, Eisenreich A, Schmidbauer M, Barysenka A, Purfürst B, Sporbert A, Lorenzen T, Meyer AM, Herlan L, Witten A, Rühle F, Zhou W, de Heer E, Scharpfenecker M, Panáková D, Stoll M, Kreutz R.

Elife. 2019 Mar 22;8. pii: e42068. doi: 10.7554/eLife.42068.

21.

Prediction of Ischemic Events after Percutaneous Coronary Intervention: Thrombelastography Profiles and Factor XIIIa Activity.

Kreutz RP, Schmeisser G, Schaffter A, Kanuri S, Owens J, Maatman B, Sinha A, von der Lohe E, Breall JA.

TH Open. 2018 Apr;2(2):e173-e181. doi: 10.1055/s-0038-1645876.

22.

XALIA-LEA: An observational study of venous thromboembolism treatment with rivaroxaban and standard anticoagulation in the Asia-Pacific, Eastern Europe, the Middle East, Africa and Latin America.

Kreutz R, Mantovani LG, Haas S, Monje D, Schneider J, Bugge JP, Gebel M, Tamm M, Ageno W, Turpie AGG.

Thromb Res. 2019 Apr;176:125-132. doi: 10.1016/j.thromres.2019.02.010. Epub 2019 Feb 13.

23.

[2018 ESC/ESH Guidelines for the management of arterial hypertension].

Williams B, Mancia G, Spiering W, Rosei EA, Azizi M, Burnier M, Clement DL, Coca A, de Simone G, Dominiczak A, Kahan T, Mahfoud F, Redon J, Ruilope L, Zanchetti A, Kerins M, Kjeldsen SE, Kreutz R, Laurent S, Lip GYH, McManus R, Narkiewicz K, Ruschitzka F, Schmieder RE, Shlyakhto E, Tsioufis C, Aboyans V, Desormais I.

Kardiol Pol. 2019;77(2):71-159. doi: 10.5603/KP.2019.0018. Polish. No abstract available.

24.

Control of blood pressure and risk of mortality in a cohort of older adults: the Berlin Initiative Study.

Douros A, Tölle M, Ebert N, Gaedeke J, Huscher D, Kreutz R, Kuhlmann MK, Martus P, Mielke N, Schneider A, Schuchardt M, van der Giet M, Schaeffner E.

Eur Heart J. 2019 Jul 1;40(25):2021-2028. doi: 10.1093/eurheartj/ehz071.

PMID:
30805599
25.

Longitudinal kidney function trajectories predict major bleeding, hospitalization and death in patients with atrial fibrillation and chronic kidney disease.

Posch F, Ay C, Stöger H, Kreutz R, Beyer-Westendorf J.

Int J Cardiol. 2019 May 1;282:47-52. doi: 10.1016/j.ijcard.2019.01.089. Epub 2019 Jan 27.

PMID:
30777405
26.

[Comments on the guidelines (2018) of the European Society of Cardiology (ESC) and the European Society of Hypertension (ESH) on the management of arterial hypertension].

Mahfoud F, Böhm M, Bongarth CM, Bosch R, Schmieder RE, Schunkert H, Stellbrink C, Trenkwalder P, Vonend O, Weil J, Kreutz R.

Internist (Berl). 2019 Apr;60(4):424-430. doi: 10.1007/s00108-019-0576-9. Review. German.

PMID:
30770942
27.

Pharmacogenomics of Novel Direct Oral Anticoagulants: Newly Identified Genes and Genetic Variants.

Kanuri SH, Kreutz RP.

J Pers Med. 2019 Jan 17;9(1). pii: E7. doi: 10.3390/jpm9010007. Review.

28.

Importance of in vitro conditions for modeling the in vivo dose in humans by in vitro-in vivo extrapolation (IVIVE).

Algharably EAH, Kreutz R, Gundert-Remy U.

Arch Toxicol. 2019 Mar;93(3):615-621. doi: 10.1007/s00204-018-2382-x. Epub 2019 Jan 2.

PMID:
30604139
29.

[Pharmacology of non-opioid analgesics].

Schneider J, Kreutz R, Bolbrinker J.

Schmerz. 2019 Apr;33(2):165-179. doi: 10.1007/s00482-018-0339-x. German.

PMID:
30535850
30.

[2018 ESC/ESH Guidelines for the management of arterial hypertension. The Task Force for the management of arterial hypertension of the European Society of Cardiology (ESC) and the European Society of Hypertension (ESH)].

Williams B, Mancia G, Spiering W, Rosei EA, Azizi M, Burnier M, Clement DL, Coca A, de Simone G, Dominiczak A, Kahan T, Mahfoud F, Redon J, Ruilope L, Zanchetti A, Kerins M, Kjeldsen SE, Kreutz R, Laurent S, Lip GYH, McManus R, Narkiewicz K, Ruschitzka F, Schmieder RE, Shlyakhto E, Tsioufis C, Aboyans V, Desormais I.

G Ital Cardiol (Rome). 2018 Nov;19(11 Suppl 1):3S-73S. doi: 10.1714/3026.30245. Italian. No abstract available.

PMID:
30520455
31.

ESH Annual Meeting 2018: Reinhold Kreutz reports on the 28th European Meeting on Hypertension and Cardiovascular Protection that took place in Barcelona, Spain, 8-11 June.

Tsioufis K, Kreutz R.

Eur Heart J. 2018 Nov 14;39(43):3836-3839. doi: 10.1093/eurheartj/ehy667. No abstract available.

PMID:
30428033
32.

Pharmacokinetics of Daclatasvir, Sofosbuvir, and GS-331007 in a Prospective Cohort of Hepatitis C Virus-Positive Kidney Transplant Recipients.

Schrezenmeier E, Hoffmann F, Jaeger C, Schrezenmeier J, Lisec J, Glander P, Algharably E, Kreutz R, Budde K, Duerr M, Halleck F.

Ther Drug Monit. 2019 Feb;41(1):53-58. doi: 10.1097/FTD.0000000000000567.

PMID:
30422962
33.

2018 Practice Guidelines for the management of arterial hypertension of the European Society of Cardiology and the European Society of Hypertension.

Williams B, Mancia G, Spiering W, Agabiti Rosei E, Azizi M, Burnier M, Clement D, Coca A, De Simone G, Dominiczak A, Kahan T, Mahfoud F, Redon J, Ruilope L, Zanchetti A, Kerins M, Kjeldsen S, Kreutz R, Laurent S, Lip GYH, McManus R, Narkiewicz K, Ruschitzka F, Schmieder R, Shlyakhto E, Tsioufis K, Aboyans V, Desormais I.

Blood Press. 2018 Dec;27(6):314-340. doi: 10.1080/08037051.2018.1527177. Review. Erratum in: Blood Press. 2019 Feb;28(1):74.

PMID:
30380928
34.

2018 Practice Guidelines for the management of arterial hypertension of the European Society of Hypertension and the European Society of Cardiology: ESH/ESC Task Force for the Management of Arterial Hypertension.

Williams B, Mancia G, Spiering W, Agabiti Rosei E, Azizi M, Burnier M, Clement D, Coca A, De Simone G, Dominiczak A, Kahan T, Mahfoud F, Redon J, Ruilope L, Zanchetti A, Kerins M, Kjeldsen S, Kreutz R, Laurent S, Lip GYH, McManus R, Narkiewicz K, Ruschitzka F, Schmieder R, Shlyakhto E, Tsioufis K, Aboyans V, Desormais I; List of authors/Task Force members:.

J Hypertens. 2018 Dec;36(12):2284-2309. doi: 10.1097/HJH.0000000000001961. No abstract available. Erratum in: J Hypertens. 2019 Feb;37(2):456.

PMID:
30379783
35.

Finerenone Attenuates Endothelial Dysfunction and Albuminuria in a Chronic Kidney Disease Model by a Reduction in Oxidative Stress.

González-Blázquez R, Somoza B, Gil-Ortega M, Martín Ramos M, Ramiro-Cortijo D, Vega-Martín E, Schulz A, Ruilope LM, Kolkhof P, Kreutz R, Fernández-Alfonso MS.

Front Pharmacol. 2018 Oct 9;9:1131. doi: 10.3389/fphar.2018.01131. eCollection 2018.

36.

Increased dynamin expression precedes proteinuria in glomerular disease.

Khalil R, Koop K, Kreutz R, Spaink HP, Hogendoorn PC, Bruijn JA, Baelde HJ.

J Pathol. 2019 Feb;247(2):177-185. doi: 10.1002/path.5181. Epub 2018 Nov 27.

37.
38.

Healthcare resource use in XALIA: A subgroup analysis of a non-interventional study of rivaroxaban versus standard anticoagulation for deep vein thrombosis.

Mantovani LG, Haas S, Kreutz R, Folkerts K, Gebel M, Monje D, Schneider J, van Eickels M, Sahin K, Zell E, Ageno W, Turpie AGG.

Eur J Intern Med. 2019 Mar;61:29-33. doi: 10.1016/j.ejim.2018.10.002. Epub 2018 Oct 19.

39.

Next generation MicroRNA sequencing to identify coronary artery disease patients at risk of recurrent myocardial infarction.

Kanuri SH, Ipe J, Kassab K, Gao H, Liu Y, Skaar TC, Kreutz RP.

Atherosclerosis. 2018 Nov;278:232-239. doi: 10.1016/j.atherosclerosis.2018.09.021. Epub 2018 Oct 3.

40.

Implementing the Proclamation of Stroke and Potentially Preventable Dementias.

Hachinski V, Ganten D, Lackland D, Kreutz R, Tsioufis K, Hacke W.

Int J Stroke. 2018 Oct;13(8):780-786. doi: 10.1177/1747493018799965.

PMID:
30328803
41.

Implementing the proclamation of stroke and potentially preventable dementias.

Hachinski V, Ganten D, Lackland D, Kreutz R, Tsioufis K, Hacke W; World Stroke Organization, the World Heart Federation, the World Hypertension League, the European Society of Hypertension.

J Clin Hypertens (Greenwich). 2018 Oct;20(10):1354-1359. doi: 10.1111/jch.13382. Epub 2018 Oct 9.

42.

Influence of Renal Function on the Pharmacokinetics, Pharmacodynamics, Efficacy, and Safety of Non-Vitamin K Antagonist Oral Anticoagulants.

Weir MR, Kreutz R.

Mayo Clin Proc. 2018 Oct;93(10):1503-1519. doi: 10.1016/j.mayocp.2018.06.018. Review.

43.

Atrial fibrillation and medication treatment among centenarians: Are all very old patients treated the same?

Kreutz R, Schmidt IM, Dräger D, Brüggen F, Hörter S, Zwillich C, Kuhlmey A, Gellert P.

Geriatr Gerontol Int. 2018 Dec;18(12):1634-1640. doi: 10.1111/ggi.13531. Epub 2018 Sep 26.

PMID:
30259631
44.

2018 ESC/ESH Guidelines for the management of arterial hypertension: The Task Force for the management of arterial hypertension of the European Society of Cardiology and the European Society of Hypertension: The Task Force for the management of arterial hypertension of the European Society of Cardiology and the European Society of Hypertension.

Williams B, Mancia G, Spiering W, Agabiti Rosei E, Azizi M, Burnier M, Clement DL, Coca A, de Simone G, Dominiczak A, Kahan T, Mahfoud F, Redon J, Ruilope L, Zanchetti A, Kerins M, Kjeldsen SE, Kreutz R, Laurent S, Lip GYH, McManus R, Narkiewicz K, Ruschitzka F, Schmieder RE, Shlyakhto E, Tsioufis C, Aboyans V, Desormais I; Authors/Task Force Members:.

J Hypertens. 2018 Oct;36(10):1953-2041. doi: 10.1097/HJH.0000000000001940. Erratum in: J Hypertens. 2019 Jan;37(1):226.

PMID:
30234752
45.

Lower Prescription Rates in Centenarians with Heart Failure and Heart Failure and Kidney Disease Combined: Findings from a Longitudinal Cohort Study of Very Old Patients.

Schmidt IM, Kreutz R, Dräger D, Zwillich C, Hörter S, Kuhlmey A, Gellert P.

Drugs Aging. 2018 Oct;35(10):907-916. doi: 10.1007/s40266-018-0581-z.

PMID:
30187290
46.

2018 ESC/ESH Guidelines for the management of arterial hypertension.

Williams B, Mancia G, Spiering W, Agabiti Rosei E, Azizi M, Burnier M, Clement DL, Coca A, de Simone G, Dominiczak A, Kahan T, Mahfoud F, Redon J, Ruilope L, Zanchetti A, Kerins M, Kjeldsen SE, Kreutz R, Laurent S, Lip GYH, McManus R, Narkiewicz K, Ruschitzka F, Schmieder RE, Shlyakhto E, Tsioufis C, Aboyans V, Desormais I; ESC Scientific Document Group .

Eur Heart J. 2018 Sep 1;39(33):3021-3104. doi: 10.1093/eurheartj/ehy339. No abstract available.

PMID:
30165516
47.

Predictive value of venous thromboembolism (VTE)-BLEED to predict major bleeding and other adverse events in a practice-based cohort of patients with VTE: results of the XALIA study.

Klok FA, Barco S, Turpie AGG, Haas S, Kreutz R, Mantovani LG, Gebel M, Herpers M, Bugge JP, Kostantinides SV, Ageno W.

Br J Haematol. 2018 Nov;183(3):457-465. doi: 10.1111/bjh.15533. Epub 2018 Aug 19.

48.

Targeted resequencing of a locus for heparin-induced thrombocytopenia on chromosome 5 identified in a genome-wide association study.

Witten A, Bolbrinker J, Barysenka A, Huber M, Rühle F, Nowak-Göttl U, Garbe E, Kreutz R, Stoll M.

J Mol Med (Berl). 2018 Aug;96(8):765-775. doi: 10.1007/s00109-018-1661-6. Epub 2018 Jun 22.

PMID:
29934777
49.

A comprehensive review and meta-analysis of risk factors for statin-induced myopathy.

Nguyen KA, Li L, Lu D, Yazdanparast A, Wang L, Kreutz RP, Whipple EC, Schleyer TK.

Eur J Clin Pharmacol. 2018 Sep;74(9):1099-1109. doi: 10.1007/s00228-018-2482-9. Epub 2018 May 22. Review.

PMID:
29785580
50.

Improving long-term adherence to statin therapy: a qualitative study of GPs' experiences in primary care.

Krüger K, Leppkes N, Gehrke-Beck S, Herrmann W, Algharably EA, Kreutz R, Heintze C, Filler I.

Br J Gen Pract. 2018 Jun;68(671):e401-e407. doi: 10.3399/bjgp18X696173. Epub 2018 Apr 23.

Supplemental Content

Loading ...
Support Center